Skip to content

Tectonic Therapeutics TECX Other income, net (Note 6)

Other income, net (Note 6) at other companies

ALN
Alnylam PharmaceuticalsALNY
-$4.3M-147%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$31K-10.7%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$29K-72.9%
Opko Health logo
Opko HealthOPK
-$1.71M-135%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$4.77M-112%
Precigen logo
PrecigenPGEN
$290K+4,043%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's other income, net (note 6)?
Tectonic Therapeutics (TECX) reported other income, net (note 6) of -$113K in Q1 2026.
How has Tectonic Therapeutics's other income, net (note 6) changed year-over-year?
Tectonic Therapeutics's other income, net (note 6) decreased by 253.1% year-over-year, from -$32K to -$113K.
What is the long-term trend for Tectonic Therapeutics's other income, net (note 6)?
Over 2 years (2023 to 2025), Tectonic Therapeutics's other income, net (note 6) has grown at a -46.3% compound annual growth rate (CAGR), from $412K to -$119K.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.